Obesity, mRNA Therapeutics, Fc Receptors
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Having trouble viewing this email? View Online

New Tools for Obesity Drug Discovery

Obesity is now recognized as a multifactorial metabolic disease. Advancing drug discovery requires precise, reliable tools to interrogate complex biology — from GPCR signaling and hormone regulation to inflammation and muscle metabolism.

adipocyte (fat cell) with labeled fat droplet

Explore solutions across key obesity research pathways:

GPCR Research Solutions: Monitor receptor signaling in real time
Metabolic Activity Assays: Measure glucose uptake with the non-radioactive Glucose Uptake-Glo™ Assay
Incretin & Myostatin Bioassays: Evaluate GLP-1R agonists and determine rank-order potency
Insulin & Glucagon Assays: Quantify critical metabolic hormones
Inflammation Assays: Profile obesity-related cytokines

Download Flyer

Wavy divider with colorful microscopic cells and particles

mRNA Therapeutics in Practice

mRNA therapeutics require high-quality synthesis, precise impurity control, and robust functional characterization. This brochure highlights selected products supporting each of these critical steps.

Inside you will find:

In Vitro Transcription Reagents for efficient mRNA synthesis
dsRNA Quantification Assay to detect dsRNA impurities
Functional Characterization Systems to assess translation efficiency and immune response

Discover a practical overview to support your mRNA development workflow.

Download Brochure

Measure Fc Effector Activity with Confidence

Schematic diagram of Fc effector activity showing five immune mechanisms (ADCC, ADCP, CDC, FcγRIIb, FcγRn) interacting via CD receptors with an antibody-coated surface.

Understanding Fc-mediated functions like ADCC, ADCP, and CDC is critical for antibody development, but often complex to assess.
These Fc Effector Activity Bioassays offer a streamlined, bioluminescent solution with ready-to-use cells and scalable workflows from discovery to QC.

Available assay formats:

Lumit® FcγR Binding Immunoassays
Reporter Bioassays
HiBiT Target Cell Killing Assays

Learn More

Smiling cell cartoon character with megaphone

Cells can tell you a lot — if you know how to ask
Is a cell adapting to stress, slowing down, or heading toward apoptosis? Our interactive Cell-Based Assays Guide lets you click your way through viability, stress responses and cell death.

Science made interactive.

Explore the Interactive Cell Based Assays Guide

We've refreshed our preference center. Review your preferences here .

Manage Your Preferences | Privacy Policy | Imprint | Unsubscribe

Promega GmbH

Gutenbergring 10, 69190 Walldorf, Germany